Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc Analysis.
Saved in:
| Title: | Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc Analysis. |
|---|---|
| Authors: | Weidinger S; Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Reich K; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Issa N; Issa Research & Consulting, LLC, Springfield, VA, USA.; Dr. Philip Frost Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine Miami, Miami, FL, USA.; The Department of Dermatology, The George Washington University School of Medicine & Health Sciences, Washington, DC, USA.; Forefront Dermatology, Vienna, VA, USA., Hong HC; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada., Bunick CG; Program in Translational Biomedicine, Yale School of Medicine, New Haven, CT, USA.; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA., Biswas P; Pfizer Inc., New York, NY, USA., Chan G; Pfizer, Inc., Groton, CT, USA., Güler E; Pfizer Inc., Istanbul, Turkey., Watkins M; Pfizer Inc., New York, NY, USA., Alderfer J; Pfizer Inc., 500 Arcola Rd, Collegeville, PA, 19426, USA. justine.alderfer@pfizer.com. |
| Source: | Dermatology and therapy [Dermatol Ther (Heidelb)] 2026 Jun 27. Date of Electronic Publication: 2026 Jun 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Healthcare Communications Country of Publication: Switzerland NLM ID: 101590450 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8210 (Print) NLM ISO Abbreviation: Dermatol Ther (Heidelb) |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42365219 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc Analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Weidinger+S%22">Weidinger S</searchLink>; Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Reich+K%22">Reich K</searchLink>; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Issa+N%22">Issa N</searchLink>; Issa Research & Consulting, LLC, Springfield, VA, USA.; Dr. Philip Frost Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine Miami, Miami, FL, USA.; The Department of Dermatology, The George Washington University School of Medicine & Health Sciences, Washington, DC, USA.; Forefront Dermatology, Vienna, VA, USA.<br /><searchLink fieldCode="AU" term="%22Hong+HC%22">Hong HC</searchLink>; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Bunick+CG%22">Bunick CG</searchLink>; Program in Translational Biomedicine, Yale School of Medicine, New Haven, CT, USA.; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Biswas+P%22">Biswas P</searchLink>; Pfizer Inc., New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Chan+G%22">Chan G</searchLink>; Pfizer, Inc., Groton, CT, USA.<br /><searchLink fieldCode="AU" term="%22Güler+E%22">Güler E</searchLink>; Pfizer Inc., Istanbul, Turkey.<br /><searchLink fieldCode="AU" term="%22Watkins+M%22">Watkins M</searchLink>; Pfizer Inc., New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Alderfer+J%22">Alderfer J</searchLink>; Pfizer Inc., 500 Arcola Rd, Collegeville, PA, 19426, USA. justine.alderfer@pfizer.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101590450%22">Dermatology and therapy</searchLink> [Dermatol Ther (Heidelb)] 2026 Jun 27. <i>Date of Electronic Publication: </i>2026 Jun 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Healthcare+Communications%22">Springer Healthcare Communications </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101590450 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2193-8210 (Print) <i>NLM ISO Abbreviation: </i>Dermatol Ther (Heidelb) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42365219 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s13555-026-01833-8 Languages: – Code: eng Text: English Titles: – TitleFull: Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc Analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Weidinger S – PersonEntity: Name: NameFull: Reich K – PersonEntity: Name: NameFull: Issa N – PersonEntity: Name: NameFull: Hong HC – PersonEntity: Name: NameFull: Bunick CG – PersonEntity: Name: NameFull: Biswas P – PersonEntity: Name: NameFull: Chan G – PersonEntity: Name: NameFull: Güler E – PersonEntity: Name: NameFull: Watkins M – PersonEntity: Name: NameFull: Alderfer J IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 06 Text: 2026 Jun 27 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2193-8210 Titles: – TitleFull: Dermatology and therapy Type: main |
| ResultId | 1 |